These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35870043)

  • 21. A fatal case of acute progression of generalized edema and simultaneous flash pulmonary edema in a patient with idiopathic systemic capillary leak syndrome: a case report.
    Hirosaki Y; Hayashidani S; Ouchi S; Ohshima T; Nakano R; Yamamoto H
    J Med Case Rep; 2015 Apr; 9():90. PubMed ID: 25928289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capillary leak syndrome: etiologies, pathophysiology, and management.
    Siddall E; Khatri M; Radhakrishnan J
    Kidney Int; 2017 Jul; 92(1):37-46. PubMed ID: 28318633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous peripheral T-cell lymphomas.
    Talpur R; Duvic M
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):180-5. PubMed ID: 22521504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic systemic capillary leak syndrome - An often missed diagnosis.
    Rajan R; Kapoor N; Asha HS; Paul TV; Thomas N
    Trop Doct; 2021 Apr; 51(2):246-248. PubMed ID: 33349162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrent unexplained lipothymia: do not forget the capillary leak syndrome].
    Debourdeau P; Bory P; Zammit C; Pavic M; Colle B
    Rev Med Interne; 2007 Oct; 28(10):711-3. PubMed ID: 17321012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
    Duvic M
    Clin Lymphoma; 2000 Nov; 1 Suppl 1():S51-5. PubMed ID: 11707865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune checkpoint inhibitors-induced systemic capillary leak syndrome: A report of two cases.
    Petitdemange A; Béguin L; Dimitrov Y
    Rev Med Interne; 2023 Jan; 44(1):35-37. PubMed ID: 36404226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
    Case R; Ramaniuk A; Martin P; Simpson PJ; Harden C; Ataya A
    Chest; 2020 Dec; 158(6):e267-e268. PubMed ID: 32622823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.
    Foss FM; Bacha P; Osann KE; Demierre MF; Bell T; Kuzel T
    Clin Lymphoma; 2001 Mar; 1(4):298-302. PubMed ID: 11707845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic Systemic Capillary Leak Syndrome.
    Hajare KR; Patil P; Bansode J
    Indian J Crit Care Med; 2018 May; 22(5):369-371. PubMed ID: 29910550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma.
    Acosta M; Teitelbaum A
    J Am Acad Dermatol; 2001 Feb; 44(2):312-3. PubMed ID: 11174402
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox.
    Lewis DJ; Dao H; Nagarajan P; Duvic M
    JAAD Case Rep; 2017 Nov; 3(6):501-504. PubMed ID: 29296637
    [No Abstract]   [Full Text] [Related]  

  • 33. Two episodes of systemic capillary leak syndrome in an 8-year-old boy, following influenza A virus infection.
    Perme T; Pokorn M; Markelj G; Avčin T; Battelino T; Uršič T; Vidmar I; Grosek Š
    Pediatr Infect Dis J; 2014 Feb; 33(2):222-4. PubMed ID: 23995592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma.
    Railan D; Fivenson DP; Wittenberg G
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):323-4. PubMed ID: 10906662
    [No Abstract]   [Full Text] [Related]  

  • 35. Idiopathic systemic capillary leak syndrome (Clarkson disease).
    Druey KM; Parikh SM
    J Allergy Clin Immunol; 2017 Sep; 140(3):663-670. PubMed ID: 28012935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.
    Chin KM; Foss FM
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):199-204. PubMed ID: 17229335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The systemic capillary leak syndrome: a scarcely known nephrological entity.
    Teutonico A; Chimienti D; Antonelli M; Bruno A; Libutti P; Lisi P; Basile C
    J Nephrol; 2012; 25(2):262-5. PubMed ID: 22135035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic capillary leak syndrome causes a compartment syndrome of both lower legs and a forearm. A case report with a review of the literature].
    Balcarek P; Frosch KH; Quintel M; Stürmer KM
    Unfallchirurg; 2005 Sep; 108(9):770, 772-5. PubMed ID: 15778826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nivolumab-induced systemic capillary leak syndrome as an ultra rare life-threatening phenomenon of late toxicity and intravenous immunoglobulin efficacy.
    Polishchuk I; Yakobson A; Zemel M; A Sharb A; Shalata W; Rosenberg E; A Kian T; Alguayn F; Peled N; Rouvinov K; Alguayn W; Kian W
    Immunotherapy; 2021 Jul; 13(10):807-811. PubMed ID: 33969699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic capillary leak syndrome. Case report.
    Sabbadini DD; Peressutti R; Di Silvestre A; Lucchese F; Margarit O; Macor D; Petrei D; Salino R; Rossi P; Schiavon I; Giordano F
    Minerva Anestesiol; 2002 Dec; 68(12):929-33, 933-6. PubMed ID: 12586993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.